Your browser doesn't support javascript.
loading
DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma.
Starzer, Angelika Martina; Heller, Gerwin; Tomasich, Erwin; Melchardt, Thomas; Feldmann, Katharina; Hatziioannou, Teresa; Traint, Stefan; Minichsdorfer, Christoph; Schwarz-Nemec, Ursula; Nackenhorst, Maja; Müllauer, Leonhard; Preusser, Matthias; Berghoff, Anna Sophie; Fuereder, Thorsten.
Afiliação
  • Starzer AM; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
  • Heller G; Department of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria.
  • Tomasich E; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
  • Melchardt T; Department of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria.
  • Feldmann K; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
  • Hatziioannou T; Department of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria.
  • Traint S; Laboratory for Immunological and Molecular Cancer Research, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Minichsdorfer C; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
  • Schwarz-Nemec U; Department of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria.
  • Nackenhorst M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
  • Müllauer L; Department of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria.
  • Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
  • Berghoff AS; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
  • Fuereder T; Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
J Immunother Cancer ; 10(3)2022 03.
Article em En | MEDLINE | ID: mdl-35338086
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno B7-H1 / Neoplasias de Cabeça e Pescoço Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígeno B7-H1 / Neoplasias de Cabeça e Pescoço Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Áustria